What is Betsy D. Holden’s total DENTSPLY SIRONA (XRAY) share ownership after this transaction?

After the reported purchase, Betsy D. Holden directly owns 87,528 shares of DENTSPLY SIRONA Common Stock. This figure reflects her position immediately following the June 11, 2026 open-market transaction disclosed in the Form 4 insider trading report filed with regulators.

Director Betsy Holden buys 10,086 DENTSPLY SIRONA (XRAY) shares in open market

Filing Impact

(Neutral)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director Betsy D. Holden purchased additional shares of the company’s Common Stock in the open market. She bought 10,086 shares on June 11, 2026 at a weighted average price of $9.8842 per share. After this transaction, she directly owns 87,528 shares of DENTSPLY SIRONA Common Stock. The filing notes that the purchase price reflects multiple trades executed between $9.865 and $9.90 per share.

Insights

Director’s open-market buy modestly increases direct stake in DENTSPLY SIRONA.

Director Betsy D. Holden executed an open-market purchase of 10,086 DENTSPLY SIRONA Common Stock shares at a weighted average price of $9.8842 on June 11, 2026. This is a straightforward cash purchase, not an option exercise or equity grant.

Following the trade, her direct holdings rise to 87,528 shares. The transaction involves a single non-derivative entry with no related option exercises or complex instruments, and no reference to any Rule 10b5-1 trading plan in the provided data. Overall, this appears to be a routine insider share accumulation.

Insider Trade Summary

Net Buyer: 10,086 shares ($99,692)

Net Buy 1 txn

Insider HOLDEN BETSY D

Role null

Bought 10,086 shs ($100K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	10,086	$9.8842	$100K

Holdings After Transaction: Common Stock — 87,528 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Shares purchased: 10,086 shares Weighted average purchase price: $9.8842 per share Post-transaction holdings: 87,528 shares +2 more

5 metrics

Shares purchased 10,086 shares Open-market purchase of Common Stock on June 11, 2026

Weighted average purchase price $9.8842 per share Price for the 10,086 Common Stock shares bought

Post-transaction holdings 87,528 shares Total Common Stock directly owned after the trade

Transaction price range low $9.865 per share Lowest execution price within the reported purchase range

Transaction price range high $9.90 per share Highest execution price within the reported purchase range

Key Terms

Common Stock, open-market purchase, weighted average price

3 terms

Common Stock financial

"She bought 10,086 shares of the company’s Common Stock in the open market."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

open-market purchase financial

"She bought 10,086 shares on June 11, 2026 at a weighted average price in an open-market purchase."

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"The price reported is a weighted average price based on multiple transactions between $9.865 and $9.90."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/15/2026 - 05:01 PM Accepted by SEC EDGAR 06/15/2026 - 05:01 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HOLDEN BETSY D

(Last)

(First)

(Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE

NORTH CAROLINA

28277

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/11/2026		P		10,086	A	$9.8842⁽¹⁾	87,528	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $9.865 to $9.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Betsy D. Holden	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did DENTSPLY SIRONA (XRAY) director Betsy D. Holden report in this Form 4?

Director Betsy D. Holden reported buying 10,086 shares of DENTSPLY SIRONA Common Stock in an open-market transaction. The trade occurred on June 11, 2026 at a weighted average price of $9.8842 per share, increasing her direct ownership to 87,528 shares.

How many DENTSPLY SIRONA (XRAY) shares did Betsy D. Holden buy and at what price?

She purchased 10,086 DENTSPLY SIRONA Common Stock shares in the open market. The filing shows a weighted average purchase price of $9.8842 per share, based on multiple trades executed in a price range between $9.865 and $9.90 during the transaction.

Was the DENTSPLY SIRONA (XRAY) insider transaction an open-market purchase or something else?

The transaction was an open-market purchase of Common Stock, coded “P” in the filing. That code indicates a standard buy in the market, rather than an option exercise, tax withholding event, gift, or other non-market-related equity transaction commonly seen in insider reports.

What price range did the DENTSPLY SIRONA (XRAY) director pay for the purchased shares?

The weighted average price reported was $9.8842 per share. According to the footnote, the 10,086 shares were bought in multiple transactions, with individual trade prices ranging from $9.865 to $9.90, inclusive, across the executed orders on that date.